๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Advanced Gastric Cancer
Clinical trial register · China

Advanced Gastric Cancer Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Zhengzhou 2 Jinan 2 Shanghai 2 Harbin 1 Beijing 1
Narrow the registerReset
Recruitment status
Phase
Site location
Zhengzhou2 Jinan2 Shanghai2 Harbin1 Beijing1
All 9 locations
Target enrolment
to

Advanced Gastric Cancer trials in China

11 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Safety and Efficacy of Leucine-Restricted Diet Combined With Chemotherapy and Immunotherapy in Advanced Gastric Cancer
NCT07537348Advanced Gastric Cancer
Qilu Hospital of Shandong University
Phase 2
73
Jinan
2026-01-01
Recruiting
Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
NCT07315854Gastric Cancer (GC), Gastroesophageal Junction Cancer, Advanced Gastric Cancer, Metastatic Gastric Cancer
Beijing Friendship Hospital
Phase 2
32
Beijing
2025-11-04
Recruiting
Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma
NCT07102901Advanced Gastric Cancer, Metastatic Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
351
Harbin, Zhengzhou
2025-09-05
Recruiting
Predicting Efficacy of Preoperative Immunotherapy in Advanced Gastric Cancer
NCT07824479Advanced Gastric Cancer
Ruijin Hospital
Observational
120
Shanghai
2025-06-17
Recruiting
PDL1/TGFฮฒ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer
NCT07294664Advanced Gastric Cancer, SHR1701
The First Affiliated Hospital of Zhengzhou University
Phase 2
78
Zhengzhou
2025-06-15
Active, closed
SBRT-LDRT-Cadonilimab for Advanced Gastric, Colorectal and Ovarian Cancers With Peritoneal Metastases
NCT06940921Advanced Gastric Cancer, Advanced Colorectal Cancer, Advanced Ovarian Cancer, Peritoneal Metastasis
Zhang Tao
Phase 1/2
26
Chongqing
2025-03-20
Not yet open
The Combination of Adebrelimab, Apatinib, and Lrinotecan Liposome for Second-line Treatment of Advanced Gastric Cancer
NCT06592287Advanced Gastric Cancer
Xianglin Yuan
Phase 1/2
66
Wuhan
2024-09-30
Recruiting
Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer
NCT06346093Advanced Gastric Cancer
Changhai Hospital
Not applicable
124
Shanghai
2024-04-02
Recruiting
First-Line and Neoadjuvant Immunotherapy for Gastric Cancer
NCT06727981Advanced Gastric Cancer, Locally Advanced Gastric Carcinoma
Qilu Hospital of Shandong University
Observational
500
Jinan
2022-01-15
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/advanced-gastric-cancer

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies listing the condition Advanced Gastric Cancer.

How many Advanced Gastric Cancer trials are recruiting in China?

8 of the 11 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 2 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Advanced Gastric Cancer), 11 studies
PhaseStudiesRecruitingShare
Phase 25445.5%
Observational2218.2%
Phase 1/22018.2%
Not applicable119.1%
Phase 1119.1%

Most active sponsors

Lead sponsors with the most studies (Advanced Gastric Cancer)
Lead sponsorStudiesRecruiting
Qilu Hospital of Shandong University22
Beijing Friendship Hospital11
Changhai Hospital11
Guangdong Provincial People's Hospital10
Jia Wei11
Jiangsu HengRui Medicine Co., Ltd.11
Ruijin Hospital11
The First Affiliated Hospital of Zhengzhou University11
Xianglin Yuan10
Zhang Tao10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.